Tony T Kalajian - Net Worth and Insider Trading
Tony T Kalajian Net Worth
The estimated net worth of Tony T Kalajian is at least $1,913 dollars as of 2024-04-16. Tony T Kalajian is the Sr.VP/Chief Accounting Officer of OncoCyte Corp and owns about 750 shares of OncoCyte Corp (OCX) stock worth over $1,913. Details can be seen in Tony T Kalajian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tony T Kalajian has not made any transactions after 2020-08-03 and currently still holds the listed stock(s).
Transaction Summary of Tony T Kalajian
Tony T Kalajian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tony T Kalajian owns 2 companies in total, including OncoCyte Corp (OCX) , and First Light Acquisition Group Inc (FLAG) .
Click here to see the complete history of Tony T Kalajian’s form 4 insider trades.
Insider Ownership Summary of Tony T Kalajian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2020-08-03 | SVP-Chief Accounting Officer |
| FLAG | First Light Acquisition Group Inc | 2023-09-12 | Chief Acctg Officer & Int. CFO |
Tony T Kalajian Latest Holdings Summary
Tony T Kalajian currently owns a total of 1 stock. Tony T Kalajian owns 750 shares of OncoCyte Corp (OCX) as of August 3, 2020, with a value of $1,913.
Latest Holdings of Tony T Kalajian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2020-08-03 | 750 | 2.55 | 1,913 |
Holding Weightings of Tony T Kalajian
Tony T Kalajian Form 4 Trading Tracker
According to the SEC Form 4 filings, Tony T Kalajian has made a total of 2 transactions in OncoCyte Corp (OCX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 250 shares on August 3, 2020, which cost Tony T Kalajian around $6,550.
Insider Trading History of Tony T Kalajian
- 1
Tony T Kalajian Trading Performance
GuruFocus tracks the stock performance after each of Tony T Kalajian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tony T Kalajian is 5.41%. GuruFocus also compares Tony T Kalajian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tony T Kalajian within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tony T Kalajian's insider trading performs compared to the benchmark.
Performance of Tony T Kalajian
Average Relative Return
84.22%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -17.73 | 5.41 | 121.83 | 84.22 | 6.6 | -36.3 |
| Relative Return to S&P 500(%) | -19.55 | 1.59 | 118.63 | 61.55 | -10.49 | -46.45 |
Tony T Kalajian Ownership Network
Ownership Network List of Tony T Kalajian
Ownership Network Relation of Tony T Kalajian
Tony T Kalajian Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Tony T Kalajian is the SVP-Chief Accounting Officer of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Tony T Kalajian made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 283,898 shares made by Andrew Arno , and a net purchase of 55,000 shares made by Alfred D Kingsley .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 2,457,288 shares, with a net purchase of 2,457,288 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,850,820 shares were bought by its insiders, resulting in a net purchase of 3,850,820 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Tony T Kalajian Mailing Address
Above is the net worth, insider trading, and ownership report for Tony T Kalajian. You might contact Tony T Kalajian via mailing address: 1010 Atlantic Avenue, Suite 102, Alameda Ca 94501.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
